Sfmg LLC decreased its position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 10.4% in the second quarter, Holdings Channel reports. The fund owned 9,047 shares of the company’s stock after selling 1,046 shares during the period. Sfmg LLC’s holdings in Kimberly-Clark were worth $1,250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of KMB. Price T Rowe Associates Inc. MD lifted its position in Kimberly-Clark by 19.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock worth $762,279,000 after acquiring an additional 944,920 shares during the last quarter. Wulff Hansen & CO. lifted its position in Kimberly-Clark by 13,720.0% during the 2nd quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock worth $88,659,000 after acquiring an additional 636,882 shares during the last quarter. Marshall Wace LLP lifted its position in Kimberly-Clark by 48.4% during the 2nd quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after acquiring an additional 503,839 shares during the last quarter. Capital World Investors raised its position in shares of Kimberly-Clark by 23.8% during the fourth quarter. Capital World Investors now owns 1,926,702 shares of the company’s stock valued at $234,114,000 after buying an additional 370,094 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Kimberly-Clark by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock valued at $267,383,000 after buying an additional 354,501 shares during the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.
Kimberly-Clark Price Performance
Shares of Kimberly-Clark stock opened at $141.06 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. The stock has a market capitalization of $47.51 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 3.00 and a beta of 0.39. Kimberly-Clark Co. has a 1-year low of $116.32 and a 1-year high of $149.30. The firm’s 50-day moving average price is $142.27 and its two-hundred day moving average price is $136.39.
Kimberly-Clark Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 2nd. Stockholders of record on Friday, September 6th will be paid a dividend of $1.22 per share. The ex-dividend date is Friday, September 6th. This represents a $4.88 annualized dividend and a dividend yield of 3.46%. Kimberly-Clark’s dividend payout ratio (DPR) is currently 89.71%.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on KMB shares. Argus raised shares of Kimberly-Clark to a “hold” rating in a research report on Friday, July 26th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $165.00 price objective on shares of Kimberly-Clark in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Kimberly-Clark from $139.00 to $142.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Wells Fargo & Company cut their price objective on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Finally, Bank of America raised shares of Kimberly-Clark from an “underperform” rating to a “buy” rating and upped their price objective for the company from $115.00 to $160.00 in a research report on Thursday, June 13th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $145.67.
Read Our Latest Analysis on Kimberly-Clark
Insider Activity
In other news, insider Jeffrey P. Melucci sold 37,699 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the sale, the insider now directly owns 19,935 shares of the company’s stock, valued at $2,819,207.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the stock in a transaction on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the sale, the insider now directly owns 7,377 shares in the company, valued at $1,038,976.68. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jeffrey P. Melucci sold 37,699 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares in the company, valued at $2,819,207.70. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Kimberly-Clark Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
- Five stocks we like better than Kimberly-Clark
- What does consumer price index measure?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How Technical Indicators Can Help You Find Oversold Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the Dogs of the Dow Strategy? Overview and Examples
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.